User:JasonEFarley

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN

Dr. Jason E. Farley is a Professor of Nursing at The Johns Hopkins University School of Nursing. He is an infectious disease-trained nurse epidemiologist and a nurse practitioner in the Division of Infectious Diseases at The Johns Hopkins School of Medicine. His research develops strategies to optimize diagnoses, navigation, linkage, engagement, and retention in care for persons with infectious diseases.

Dr. Farley is the HIV Prevention Trials Network (HPTN) site leader for Johns Hopkins School of Medicine and the lead investigator for a number of SARS-CoV-2/COVID-19 studies in collaboration with the COVID-19 Vaccine Prevention Network (CoVPN).[2] He is the lead investigator on a cluster-randomized trial [R01AI104488] designed to tailor nurse case management for persons with drug-resistant Tuberculosis and HIV co-infection in South Africa and a co-investigator on an adaptive, SMART trial [R01 NR016650], which involves an adaptive randomized evaluation of nurse-led HIV treatment retention interventions for female sex workers living with HIV, also in South Africa.

Dr. Farley leads The Johns Hopkins School of Nursing REACH Initiative, a Nursing Center whose mission is to design and improve care processes that improve outcomes for people with infectious disease. The Center works closely with the Baltimore City Health Department to improve HIV prevention, treatment, and care services.

EDUCATION

 * 2008- Doctor of Philosophy-  Johns Hopkins University School of Nursing, Baltimore, MD
 * 2003- Master of Science- Johns Hopkins University School of Nursing, Baltimore, MD
 * 2000- Master of Public Health- University of Alabama, Birmingham School of Public Health, Birmingham, AL
 * 1998-Bachelor of Science- The University of Alabama Capstone College of Nursing, Tuscaloosa, AL

Fellowships


 * 2008 – 2010- Clinical Research Scholars Program (KL2)- The Johns Hopkins University School of Medicine
 * 2006-             Medical Microbiology Research Fellowship- The Johns Hopkins University School of Medicine
 * 2006 – 2007- Fogarty Fellowship in Global Health- The Johns Hopkins Bloomberg School of Public Health
 * 2004 – 2005-  Health Disparities Fellowship- The Johns Hopkins University School of Nursing
 * 1998 – 1999-  Federal Traineeship in Epidemiology- The University of Alabama, Birmingham School of Public Health

CAREER
In 1998-2000, Dr. Farley started his career as a Clinical Research Nurse at Tuscaloosa Research Education Corp. Veterans Affairs Medical Center in Tuscaloosa. Alabama. In the year 2000, he became a Research Services Program Coordinator at Johns Hopkins University Department of Hospital Epidemiology and Infection Control in Baltimore, MD. Dr. Farley held several positions with the John Hopkins University and Healthcare systems from 2001-2017 which include: Float Pool RN (PRN), Infection Control Epidemiologist, Adult Nurse Practitioner, and Part-time Clinical Instructor.

Since 2011 Dr. Farley has held several impactful positions within the healthcare system which includes the following:


 * 2011-12- Clinical Consultant- Pennsylvania Mid-Atlantic AETC, HIV/AIDS Clinical Consultant Depart. of Corrections, Telemedicine Program
 * 2013-18- Director/PI- Johns Hopkins School of Nursing AIDS Education &Training Center(AETC) for Nurse Practitioner Education
 * 2014-19- Associate Professor- Johns Hopkins University School of Nursing
 * 2016-17- Executive Director (Interim)- Association of Nurses in AIDS Care (ANAC) Akron, Ohio
 * 2013-20- HPTN Site Lead, BWI – Johns Hopkins University AIDS Clinical Trials Group (ACTG)/HIV Prevention Trial Network (HPTN)

In 2008, he became an Assistant Professor for the Johns Hopkins University School of Nursing; in 2019 he holds a Tenured Professor position at the School of Nursing. Presenting Dr. Farley currently holds the following positions:


 * Regional Director- Johns Hopkins Regional Performance Site AIDS Education and Training Center
 * Co-Director, Clinical Core- Johns Hopkins Center for AIDS Research (CFAR)
 * Director/Founder- REACH Initiative at Johns Hopkins University School of Nursing
 * Adult Nurse Practitioner- Johns Hopkins University, School of Medicine, John G. Bartlett Specialty Practice, Johns Hopkins AIDS Service
 * PhD, DNP/PhD, and Post-Doctoral Fellowship Program Director- Johns Hopkins University School of Nursing
 * Site Leader / Investigator- BWI – Johns Hopkins University Clinical Trials Unit of Coronavirus Prevention Network (CoVPN)
 * Endowed Chair of Nursing- Johns Hopkins University School of Nursing

ADJUNCT FACULTY APPOINTMENTS


 * 2020 – Present - Adjunct Professor University of Sydney- Sydney, Australia
 * 2013 – Present- Adjunct Professor University of KwaZulu Natal (Honorary) KwaZulu Natal, South Africa
 * 2013 – 2020- Adjunct Professor University of Technology Sydney (Honorary) Sydney, Australia
 * 2009 – 2011- Adjunct Faculty, Stellenbosch University Cape Town, South Africa

HONORS AND AWARDS
In addition to Dr. Farley's work in the healthcare community; he has received numerous honors and awards highlighting some of his accomplishments:


 * 2020- COVID-19 Courage Award in the category of Science, supported by The Robert Wood Johnson Foundation, American Academy of Nursing
 * 2020- International Nurse Researcher Hall of Fame, Sigma Theta Tau International
 * 2019- Diversity Trailblazer Award, Johns Hopkins University School of Nursing
 * 2019- Fellow, American Academy of Nurse Practitioners (FAANP)
 * 2018- Global Achievement Award, Johns Hopkins University Alumni Association
 * 2017- Gene Tranbarger Writing Award Winner, American Association for Men in Nursing
 * 2016- International Association of Providers in AIDS Care (IAPAC) – 150 Most Influential People in HIV/AIDS
 * 2015- Alabama Nursing Hall of Fame
 * 2013- Fellow, American Academy of Nursing (FAAN)
 * 2012-15- Nurse Faculty Scholar, Robert Wood Johnson Foundation
 * 2010- VIP List of Professionals Under 40, The Daily Record
 * 2010- Blue Ribbon Abstract Award for Excellence Association of Professional in Infection Control (APIC)
 * 2008- New Investigator Award, Johns Hopkins Center for Nursing Research
 * 2003- Graduate Leadership Award, Johns Hopkins University School of Nursing
 * 2003- Blue Ribbon Abstract Award for Excellence Association of Professionals in Infection Control (APIC) National Conference
 * 2002- Margo Capra Award for Excellence in Hospital Epidemiology & Infection Control Association of Professionals in Infection Control
 * 1997-98- Veterans Affairs Learning Opportunities Resident (VALOR) Veterans Affairs Medical Center; Tuscaloosa, Alabama
 * 1995-97- James Fitts Alston Scholarship; University of Alabama
 * 1994-95- Freshman Honors Scholarship; University of Alabama

ACTIVE RESEARCH AND EDUCATIONAL GRANTS
Sponsored Research Grants and Projects


 * 2020 – 2025	Ending the HIV Epidemic (EHE). Baltimore City Health Department, Health Resources Services Administration (HRSA). Total Direct Costs: $725,653 [Year 1]. Role: Principal Investigator/Project Director; 10% effort. As PI, I will lead the development, implementation, and overall monitoring and evaluation of the EHE project.
 * 2020 – 2025	Integrated HIV Programs to Support Ending the HIV Epidemic in Baltimore City. Total Direct Costs: $275,951 [Year 1]. Role: Principal Investigator/Project Director; 10% effort. As PI, I will lead the development, implementation, and overall monitoring and evaluation of the EHE project.
 * 2020 – 2022	Community Collaboration to Combat Coronavirus (C-Forward). Johns Hopkins COVID Community Research Initiative. Total Costs: $3,222,658. Role: Principal Investigator (Multiple PI: Farley, Mehta, Jennings); In Kind. As Co-PI, I will work with the team to set the scientific direction of the work, define goals, work plans, and be accountable for the outcomes of the work.
 * 2020 – 2021	SARS-CoV-2 Prevalence Study. (CoVPN 5002). Lead Investigator: Farley; COVID-19 Prevention Network (HVTN)/HIV Prevention Trials Network (CoVPN). Total Direct Costs $1,750,702. Role: Site-PI; 10% effort. I provide comprehensive coordination of all logistical aspects of the study as well as developing the recruitment and retention plan. I am also responsible for all oversight regarding conduct of this trial including research team members and co-investigators.
 * 2020 – 2021	A prospective study of acute immune responses to SARS-CoV-2 Infection (CoVPN 5001). Lead Investigator: Farley; COVID-19 Prevention Network (HVTN)/HIV Prevention Trials Network (CoVPN). Total Direct Costs $75,306. Role: Site-PI; 10% effort. I provide comprehensive coordination of all logistical aspects of the study as well as developing the recruitment and retention plan. I am also responsible for all oversight regarding conduct of this trial including research team members and co-investigators.
 * 2020 – 2021	Characterizing SARS-CoV-2-specific immunity in convalescent individuals - HVTN 405/HPTN 1901. Lead Investigator: Farley; HIV Vaccine Trials Network (HVTN)/HIV Prevention Trials Network (HPTN); NIH/NIAID. Total Direct Costs $59,277. Role: Site-PI; 10% effort. I provide comprehensive coordination of all logistical aspects of the study as well as developing the recruitment and retention plan. I am also responsible for all oversight regarding conduct of this trial including research team members and co-investigators.
 * 2020 – 2021	Community Collaboration to Combat Coronavirus (C-FORWARD). Johns Hopkins COVID Community Research Initiative. Total Direct Costs: $950,000. Role: Principal Investigator (Multiple PI; Farley, Mehta, Jennings); In-Kind. As Co-PI, I will work with the team to set the scientific direction of the work, define goals and work plans and be accountable for the outcomes of the work.
 * 2019 – 2021	Leveraging, Enabling, and Advancing CHW’s through m-health to Improve TB/HIV Patient Outcome (LEAP). Johns Hopkins Discovery Award. Total Direct Costs: $99,995. Role: Co-Principal Investigator; In-Kind. As Co-PI, I will work with the team to set the scientific direction of the work, define goals and work plans and be accountable for the outcomes of the work.
 * 2016 – 2021	An Adaptive Randomized Evaluation of Nurse-Led HIV Treatment Retention Interventions for Women Living with HIV. National Institute of Nursing Research (NINR). R01 NR016650-01.  Total Direct Costs: $2,497,572.  Role: Co-Investigator; 5% effort.  As Co-I on this project, I will help further tailor the peer-led case management strategies for optimal care outcomes based on prior case management work in the US and South Africa.

Peerviewed

 * 1) Geiger, K., Stamper, P. D., & Farley, J. E. (in press). The effects of MDR/RR-TB treatment on HIV disease: A systematic review of the literature. PLoS One.
 * 2) *Farley, J. E, Ndjeka, N., Mlandu, K., Lowensen, K., Geiger, K., Nguyen, Y., Budhathoki, C., Ndjeka, N., & Stamper, P.D. (in press). Preparing the healthcare workforce in South Africa for short-course rifampicin-resistant TB treatment: Inter-professional training and task-sharing considerations. Human Resources for Health.
 * 3) *Farley, J. E., Dangerfield II, D. T., LaRicci, J., Sacamano, P., Heidari, O., Lowensen, K., Jennings, J. M., Tobin, K. (in press). Community engagement and linkage to care efforts by peer community-health workers to increase PrEP uptake among sexual minority men. Public Health Nursing (PHN).
 * 4) Hahn, E., Black, J., Maharaj, R., Farley, J. E., Redd, A. D., Reynolds, S. J., Quinn, T. C., Hansoti, B. (in press). Determining the prevalence of tuberculosis in emergency departments in the Eastern Cape region of South Africa and the utility of the WHO TB screening tool. South African Medical Journal (SAMJ).
 * 5) *Geiger, K., Bergman, A., & Farley, J. E. (in press). Evaluating integrated care for people living with HIV and multidrug-resistant tuberculosis in South Africa: A case-based approach using the chronic care model. Journal of the Association of Nurses in AIDS Care (JANAC).
 * 6) *Makado, L., Davhana-Maselesele, M., Farley, J. E., & Chueng, M. J. (in press). Adherence to treatment guidelines among nurses initiating and managing ART in South Africa. Southern African Journal of Infectious Diseases (SAJID).
 * 7) *Irvin, R., Malone, J., Gamble, T., Hughes, J., Farley, J. E., Mayer, K., H., del Rio, C., Batey, D. S., Murphy, M., Laeyendecker, O., Mabvakure, B., Remien, R., Beyrer, C. & Thio, C. (2020). HPTN 078: High Prevalence of HCV Antibodies Among Urban U.S. Men Who Have Sex with Men (MSM) Independent of HIV Status. Clinical Infectious Diseases (CID). E-pub ahead of print: https://pubmed.ncbi.nlm.nih.gov/33346798/. doi: 10.1093/cid/ciaa1869. PMID: 33346798. PMCID: None.
 * 8) *Wu, L., Schumacher, C., Chandran, A., Fields, E., Price, A., Greenbaum, A., Jennings, J. M., & the IMPACT Partner Collaborative (Page, K., Davis, M., Schamlzle, S., Jones, J. L., Farley, J. E., Arrington-Sanders, R., Tepper, V., & Demissew, M.). (2020). Patterns of PrEP Retention among HIV Pre-Exposure Prophylaxis Users in Baltimore City, Maryland. Journal of Acquired Immune Deficiency Syndromes (JAIDS), 85(5):593-600. E-pub ahead of print: https://pubmed.ncbi.nlm.nih.gov/32947447/. doi: 10.1097/QAI.0000000000002506. PMID: 32947447. PMCID: None.
 * 9) Rosa, W. E., Fitzgerald, M., Davis, S., Farley, J. E., Khanyola, J., Kwong, J., Moreland, P. J., Rogers, M., Sibanda, B., & Turale, S. (2020). Leveraging nurse practitioners’ capacities to achieve global health for all: COVID-19 and beyond. International Nursing Review. E-pub ahead of print: https://onlinelibrary.wiley.com/doi/10.1111/inr.12632. doi: https://doi.org/10.1111/inr.12632. PMID: 33006173. PMCID: PMC7537537.
 * 10) *Fogel, J. M., Bonsall, D., Cummings, V., Bowden, R., Golubchik, T., de Cesare, M., Wilson, E., Gamble, T., del Rio, C., Batey, D.S., Mayer, K., Farley, J. E., Hughes, J., Remien, R., Beyrer, C., Fraser, C., & Eshleman, S. (2020). Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load. Journal of Antimicrobial Chemotherapy (JAC), 75(12): 3510-3516. E-pub ahead of print: https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkaa352/5890039. doi:10.1093/jac/dkaa352. PMID: 32772080. PMCID: PMC7662169.
 * 11) Chandran, A., Long, A., Price, A., Murray, J., Fields, E. L., Schumacher, C. M., Greenbaum, A., Jennings, J. M., & the IMPACT Partner Collaborative (Page, K., Davis, M., Schamlzle, S., Jones, J. L., Farley, J. E., Arrington-Sanders, R., Tepper, V., & Demissew, M.). (2020). The Association Between Social Support, Violence, and Social Service Needs Among a Select Sample of Urban Adults in Baltimore City. Journal of Community Health, 45:987–996. E-pub ahead of print: https://pubmed.ncbi.nlm.nih.gov/32303919/. doi: 10.1007/s10900-020-00817-9. PMID: 32303919. PMCID: None.
 * 12) *Dandachi, D., Geiger, G., Montgomery, M. W., Karmen-Tuohy, B. S., Golzy, M., Antar, A., Llibre, J. M., Camazine, M., Diaz-De Santiago, A., Carlucci, P. M., Zacharioudakis, I. M., Rahimian, J., Wanjalla, C. N., Slim, J., Arinze, F., Kratz, A. P., Jones, J. L., Patel, S. M., Kitchell, E., Francis, A., Ray, M., Koren, D. E., Baddley, J. W., Hill, B., Sax, P. E., Chow, J., & the HIV-COVID-19 consortium. (2020). Characteristics, comorbidities, and outcomes in a multicenter registry of patients with HIV and coronavirus disease-19. Clinical Infectious Diseases. E-pub ahead of print: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1339/5903368. doi: https://doi.org/10.1093/cid/ciaa1339. PMID: 32905581. PMCID: PMC7499544.
 * 13) Silhol, R., Bioly, M., Dimitrov, D., German, D., Flynn, C., Farley, J. E., Gelman, M., Hughes, J., Donnell, D., Adeyeye, A., Remien, R., Beyrer, C., Paz-Bailey, G., Wejnert, C., & Mitchell, K. (2020). Understanding the HIV epidemic among MSM in Baltimore: A modelling study estimating the impact of past HIV infections and who acquired and contributed to infections. Journal of Acquired Immune Deficiency Syndromes (JAIDS), 84(3):253-262. E-pub ahead of print: https://www.ncbi.nlm.nih.gov/pubmed/32141958. doi: 10.1097/QAI.0000000000002340. PMID: 32141958. PMCID: None.
 * 14) *Hong, H., Dowdy, D. W., Dooley, K. E., Francis, H. W., Budhathoki, C., Han, H. & Farley, J. E. (2020). Prevalence of pre-existing hearing loss among patients with drug-resistant tuberculosis in South Africa. American Journal of Audiology (AJA), 29(2): 199-205. E-pub ahead of print: https://www.ncbi.nlm.nih.gov/pubmed/32320639. doi: 10.1044/2020_AJA-19-00103. PMID: 32320639. PMCID: None.
 * 15) *Starbird, L. E., Hong, H., Sulkowski, M. & Farley, J. E. (2020). Management of the patient with HIV/hepatitis C drug interactions: A guide for nurses and nurse practitioners.  Journal of the Association of Nurses in AIDS Care (JANAC), 31(2):241-248. E-pub ahead of print: https://www.ncbi.nlm.nih.gov/pubmed/31855873. doi:10.1097/JNC.0000000000000144. PMID: 31855873. PMCID: PMC31855873.
 * 16) *Starbird, L. E., Sulkowski, M. S., Budhathoki, C., Han, H., Reynolds, N. R. & Farley, J. E. (2020). Nurse case management to improve the hepatitis C care continuum in HIV co-infection:  Results of a randomized controlled trial. Journal of Viral Hepatitis (JVH), 27(4):376-386. E-pub ahead of print: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13241. doi: 10.1111/jvh.13241. PMID: 31750598. PMCID: PMC7080578.
 * 17) *Hong, H., Dowdy, D. W., Dooley, K. E., Francis, H. W., Budhathoki, C., Han, H. & Farley, J. E. (2020). Risk of hearing loss among multidrug-resistant TB patients according to cumulative aminoglycoside dose. International Journal of Tuberculosis and Lung Disease (IJTLD).24(1):65-72(8).  doi: 10.5588/ijtld.19.0062. PMID: 32005308. PMCID: PMC7594545.
 * 18) *Fogel, J. M., Sivay, M., Cummings, V., Wilson, E., Hart, S., Gamble, T., Laeyendecker, O., Fernandez, R. E., del Rios, C., Batey, D. S., Mayer, K., Farley, J. E., McKinstry, L., Hughes, J. P., Remien, R. H., Beyrer, C., & Eshleman, S. H. (2020). HIV drug resistance in a cohort of HIV-infected men who have sex with men in the United States. AIDS, 34(1): 91-101. E-pub ahead of print: https://www.ncbi.nlm.nih.gov/pubmed/31634196. doi: 10.1097/QAD.0000000000002394. PMID: 31634196. PMCID: PMC7144622.
 * 19) *Schumacher, C., Wu, L., Chandran, A., Fields, E., Price, A., Greenbaum, A., Jennings, J. M., & the IMPACT Partner Collaborative (Page, K., Davis, M., Schamlzle, S., Jones, J. L., Farley, J. E., Arrington-Sanders, R., Tepper, V., & Demissew, M.). (2019). STI Screening among gay, bisexual, and other men who have sex with men prescribed PrEP in Baltimore City, Maryland. Clinical Infectious Diseases, 71(10): 2637-2644. E-pub ahead of print: https://pubmed.ncbi.nlm.nih.gov/31761944/. doi: 10.1093/cid/ciz1145. PMID: 31761944. PMCID: None.
 * 20) *Farley, J. E., McKenzie-White, J., Bollinger, R., Hong, H., Lowensen. K., Chang, L., Stamper, P., Berrie, L., Olsen, F., Isherwood, L., Ndjeka, N., & Stevens, W. (2019). Evaluation of the miLINC solution to shorten time from clinical presentation to treatment initiation for RR-TB. The International Journal of Tuberculosis and Lung Disease (IJTLD), 23(9); 980-988. doi: 10.5588/ijtld.18.0503. Online publication:  https://www.ingentaconnect.com/contentone/iuatld/ijtld/2019/00000023/00000009/art00004. PMID: 31615604. PMCID: None.
 * 21) *Hong, H., Dowdy, D. W., Dooley, K. E., Francis, H. W., Budhathoki, C., Han, H. & Farley, J. E. (2019). Aminoglycoside-induced hearing loss among patients being treated for drug-resistant tuberculosis in South Africa: A prediction model.  Clinical Infectious Diseases (CID), 70(5): 917-924.doi: 10.1093/cid/ciz289.  Online publication: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz289/5432319. PMID: 30963176. PMCID: PMC7456344.
 * 22) *Hong, H., Dooley, K., Starbird, L., Francis, H. W. & Farley, J. E. (2019). Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.  Archives of Toxicology, 93(5): 1385-1399. doi: 10.1007/s00204-019-02407-8. Online publication:  https://link.springer.com/article/10.1007%2Fs00204-019-02407-8. PMID: 30963202. PMCID: PMC6667179.
 * 23) *Whitehouse, E. R., Perrin, N., Levitt, N., Hill, M., & Farley, J. E. (2019). Cardiovascular risk prevalence in South Africans with drug-resistant tuberculosis: a cross-sectional study. The International Journal of Tuberculosis and Lung Disease (IJTLD), 23(5): 587-593. doi: 10.558/ijtld.18.0374. Online publication: https://www.ingentaconnect.com/contentone/iuatld/ijtld/2019/00000023/00000005/art00012.doi: 10.558/ijtld.18.0374.  PMID: 31097067. PMCID: None.
 * 24) *Dangerfield II, D. T., Farley, J. E., Holden, J., Barnes, M., Barnes, P., Jett-Gohen, M. & Gaydos, C. (2019). Acceptability of self-collecting oropharyngeal swabs for sexually transmissible infection testing among men and women.  Sexual Health, 16(3): 296-298.  doi: 10.1071/SH18209. Online publication:  https://doi.org/10.1071/SH18209. PMID: 30898197. PMCID: PMC6755068.
 * 25) *Mitchell, K. M., Hoots, B., Dimitrov, D., German, D., Flynn, C., Farley, J. E., Gelman, M., Hughes, J., Donnell, D., Adeyeye, A., Remien, R., Beyrer, C., Paz-Bailey, G., & Boily, M. (2019). Improvements in HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modeling study for HPTN 078. Journal of the International AIDS Society (JIAS), 22(3):e25246.  doi: 10.1002/jia2.25246.  Online publication: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jia2.25246. PMID: 30868739. PMCID: PMC6416473.
 * 26) *Zhang, A., Reynolds, N., Farley, J. E., Wang, X., Tan, S., & Yan, J. (2019). Preferences for an HIV prevention mobile phone app: A qualitative study among men who have sex with men in China. BMC Public Health, 19:297. doi: 10.1186/s12889-019-6617-4. Online publication: https://doi.org/10.1186/s12889-019-6617-4. PMID: 30866880. PMCID: PMC6417268.
 * 27) Comins, C. A., Schwartz, S., Phellhu, D., Guddera, V., Farley, J. E., West. N., Parmley, L., Geng, E., Beyrer, C., Dowdy, D., Mishra, S., Hausler, H., & Baral, S. (2019). Siyaphambili protocol: An evaluation of randomized, nurse-led adaptive HIV treatment interventions for cisgender female sex workers living with HIV in Durban, South Africa. Research in Nursing & Health 42(2): 107-118. doi: 10.1002/nur.21928.  Online publication: https://www.ncbi.nlm.nih.gov/pubmed/30644999. PMID: 30644999. PMCID: PMC6666398.
 * 28) *McGowan, I., Wilkin, T., Landovitz, R. J., Wu, C., Chen, Y., Marzinke, M. A, Hendrix, C. W., Richardson, P., Eshleman, S. H., Andrade, A., Chege, W., Anderson, P. L., McCauley, M. A., Farley, J. E., Mayer, K. H., Anton, P., Brand, R. M., Cranston, R. D., & Gulick, R. (2018). The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing PrEP regimens in men who have sex with men. AIDS, 33: 237-246. Online publication: https://journals.lww.com/aidsonline/fulltext/2019/02010/The_pharmacokinetics,_pharmacodynamics,_and.7.aspx. doi: 10.1097/QAD.0000000000002038.  PMID: 30557160. PMCID: PMC6714572.
 * 29) *van de Water, B. J., Silva, S., Bettger, J .P., Humphreys, J., Cunningham, C. K., & Farley, J. E. (2018). Provision of guideline-based care for drug-resistant tuberculosis in South Africa: Level of concordance between prescribing practices and guidelines. PLoS ONE, 13(11): e0203749. https://doi.org/10.1371/journal.pone.0203749. PMID: 30395565. PMCID: PMC6218024.
 * 30) *Starbird, L. E., Sulkowski, M. S., Budhathoki, C., Reynolds, N. R., Han, H., & Farley, J. E. (2018). Care2cure: A randomized controlled trial protocol for evaluating nurse case management to improve the hepatitis C care continuum within HIV primary care. Research in Nursing & Health 41(5): 417-427. Advanced online publication. Retrieved from the link: https://www.ncbi.nlm.nih.gov/pubmed/30152537. doi: 10.1002/nur21903. PMID: 30152537. PMCID: PMC6493333.
 * 31) Hong, H., Budhathoki, C, & Farley, J. E. (2018). Effectiveness of macronutrient supplementation on nutritional status and HIV/AIDS progression: A systematic review and meta-analysis.  Clinical Nutrition ESPEN, 27: 66-74.  https://doi.org/10.1016/j.clnesp.2018.06.007.  PMID: 30144895. PMCID: PMC6112859.
 * 32) Whitehouse, E., Lai, J., Golub, J., & Farley, J. E. (2018). A systematic review of the effectiveness of smoking cessation interventions among patients with tuberculosis. Public Health Action, 8(2): 37-49. doi:10.5588/pha.18.0006. PMID: 29946519. PMCID: PMC6012961.
 * 33) *Hong, H., Budhathoki, C., & Farley, J. E. (2018). Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.  International Journal of Tuberculosis and Lung Disease (IJTLD), 22(6): 667-674. doi: 10.5588/ijtld.17.0830. PMID: 29862952. PMCID: PMC6002855.
 * 34) Han, H., Kim, K., Murphy, J., Cudjoe, J., Wilson, P., Sharps, P., & Farley, J. E.  (2018). Community health worker interventions to promote psychosocial outcomes among people living with HIV – a systematic review. PLoS ONE, 13(4):e0194928. doi: 10.1371/journal.pone.0194928. https://doi.org/10.1371/journal.pone.0194928. PMID: 29689054. PMCID: PMC5915269.
 * 35) *Makhado, L., Davhana-Maselesele, M., & Farley, J. E. (2018). Barriers to tuberculosis and human immunodeficiency virus treatment guidelines adherence among nurses initiating and managing anti-retroviral therapy in KwaZulu-Natal and North West provinces. Curationis, 41(1):e1-e8. https://doi.org/10.4102/curationis.v41i1.1808. PMID: 29781696. PMCID: PMC6091579.
 * 36) *Anderson, J. C., Campbell, J., Glass, N., Decker, M. R., Perrin, N., & Farley, J. E. (2018). Impact of intimate partner violence on clinic attendance, viral suppression, and CD4 cell count of women living with HIV in an urban clinic setting. AIDS Care, 4, 399-408. doi: 10.1080/09540121.2018.1428725. PMID: 29397777. PMCID: PMC5830100.
 * 37) *van de Water, B. J., Bettger, J. P., Silva, S., Humphreys, J., Cunningham, C. K., & Farley, J. E. (2017). Time to drug-resistant tuberculosis treatment in a prospective South African cohort. Global Pediatric Health, 4, 1-8. doi: 10.1177/2333794X17744140. PMID: 29226191. PMCID: PMC5714082.
 * 38) *Tsui, S., Denison, J. A., Kennedy, C. E., Chang, L. W., Koole, O., Torpey, K., Praag, E. V., Farley, J. E., Ford, N., Stuart, L., & Wabwire-Mangen, F. (2017). Identifying models of HIV care and treatment service delivery in Tanzania, Uganda, and Zambia using cluster analysis and Delphi survey. BMC Health Services Research, 17(1): 811. doi: 10.1186/s12913-017-2772-4. PMID: 29207973. PMCID: None.
 * 39) *Pardeshi, G., Kadam, D., Chananwale, A., Deluca, A., Khobragade, P., Parande, M., Suryavanshi, N., Kinikar, A., Basavaraj, A., Girish, S., Shelke, S., Gupte, N., Farley, J. E., & Bollinger, R. (2017). TB risk perceptions among medical residents at a tertiary care center in India. Tuberculosis Research and Treatment, 2017. Online publication. https://doi.org/10.1155/2017/7514817. PMID: 29359043. PMCID: None.
 * 40) *Dangerfield II, D. T., Smith, L. R., Anderson, J., Bruce, O. Farley, J. E., & Blumenthal, R. (2017). Sexual positioning practices and sexual risk among black gay and bisexual men: A life course perspective. AIDS and Behavior, 22(6): 1919-1931. doi: 10.1007/s10461-017-1948-6. PMID: 29079948. PMCID: PMC5924576.
 * 41) *Farley, J. E., Ndjeka, N., Kelly, A. M., Whitehouse, E., Lachman, S., Budhathoki, C., Lowensen, K., Bergren, E., Mabuza, H., Mlandu, N., & van der Walt, M. (2017). Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa.  PLoS ONE, 12(8): e0182780. https://doi.org/10.1371/journal.pone.0182780. PMID: 28783758. PMCID: 5544244.
 * 42) *Farley, J. E., Starbird, L.E., Anderson, J., Lowensen, K., Ross, T., & Carroll, K. (2017). Methodologic considerations of household-level methicillin-resistant Staphylococcus aureus decolonization among persons living with HIV. American Journal of Infection Control, 45(10):1074-1080. http://dx.doi.org/10.1016/j.ajic.2017.05.010. PMID: 28684128. PMCID: PMC5791522.
 * 43) *Brody, A. A., Farley, J. E., Gillespie, G., Hickman, R., Hodges, E., Lyder, C., Palazzo, S., Ruppar, T., Schiavenato, M., & Pesut, D. (2017). Diversity dynamics: The experience of male robert wood johnson foundation nurse faculty scholars.  Nursing Outlook, 65(3): 278-288.  http://dx.doi.org/10.1016/j.outlook.2017.02.004. PMID: 28363356. PMCID: None.
 * 44) *Gulick, R. M., Wilkins, T. J., Chen, Y. Q., Landovitz, R. J., Amico, K. R., Young, A. M., Richardson, P., Marzinke, M. A., Hendrix, C. W., Marcus, C., Klingman, K. L., Chege, W., Rinehart, A. R., Rooney, J. F., Andre, P., Salata, R. A., Magnus, M., Farley, J. E., Liu, A., Frank, I., Ho, K., Santana, J., Stekler, J. D., McCauley, M., & Mayer, K. H. (2017). Phase 2 study of the safety and tolerability of maraviroc-containing regimens to prevent HIV infection in men who have sex with men (HPTN 069/ACTG A5305). Journal of Infectious Diseases, 215(2): 238 – 246. doi: 10.1093/infdis/jiw525. PMID: 27811319. PMCID: PMC5790146.
 * 45) Farley, J. E. & Treston, C. (2016). Nurses call to action: Supporting a strong global HIV nursing workforce. Journal of the Association of Nurses in AIDS Care (JANAC), 27(6): 741-744. doi: 10.1016/j.jana.2016.08.005. PMID: 27720061. PMCID: None.
 * 46) *Sacamano, P. & Farley, J. E. (2016). Behavioral and other characteristics associated with HIV viral load in an outpatient clinic.  PLoS ONE, 11(11):e0166016. doi: 10.1371/journal.pone.0166016. PMID: 27806109. PMCID: PMC5091742.
 * 47) Lipke, G., Emerson, C., McCarthy, C., Briggs, M., Farley, J. E., Verani, A. R., & Riley, P. L. (2016). Highlighting the need for more infection control practitioners in low and middle-income countries. Public Health Action, 6(3): 160-163. doi:10.5588/pha.16.0027. PMID: 27695677. PMCID: PMC5034780.
 * 48) Nathavitharana, R., Peters, J., Lederer, P., von Delft, A., Farley, J. E., Pai, M., Jaramillo, E., Raviglione, M., & Nardell, E. (2016).  Engaging health-care workers to reduce tuberculosis transmission. The Lancet Infectious Diseases, 16(8): 883–885. doi: 10.1016/S1473-3099(16)30199-2. PMID: 27477968. PMCID: None.
 * 49) *Tudor, C., van der Walt, M. L., Margot, B., Dorman, S. E., William, P. K., Gayane, Y., & Farley, J. E., (2016). Occupational risk factors for tuberculosis among health care workers in KwaZulu-Natal, South Africa. Clinical Infectious Diseases, 62(S3): 255-261. doi: 10.1093/cid/ciw046. PMID: 27118855. PMCID: PMC4845891.
 * 50) Van Cutsem, G., Isaakidis, P., Farley, J. E., Nardell, E., Volchenkov, G., & Cox, H. (2016). Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key. Clinical Infectious Diseases, 62(S3): 238-243. doi: 10.1093/cid/ciw012. PMID: 27118853. PMCID: PMC4845888.
 * 51) *Kelly, A., Smith, B., Luo, Z., Given, B., Wehrhein, T., Master, I, & Farley, J. E. (2016). Discordance between patient and clinician reports of adverse drug reactions to MDR-TB treatment. International Journal of Tuberculosis and Lung Disease (IJTLD), 20(4): 442–447. http://dx.doi.org/10.5588/ijtld.15.0318.  PMID: 26970151.  PMCID: PMC2697015.
 * 52) *Farley, J. E., Stewart, J., Kub, J., Cumpsty-Fowler, C., Lowensen, K., & Becker, K. (2016). Development of The Johns Hopkins University School of Nursing adult/geriatric primary care nurse practitioner program in HIV prevention, treatment, and care. Journal of the Association of Nurses in AIDS Care (JANAC), 3, 223-233. pii: S1055-3290(15)00290-3.  doi:10.1016/j/jana.2015.12.006. PMID: 26852319. PMCID: None.
 * 53) *Warren, N., Breman, R., Budhathoki, C., Farley, J. E., & Wilson, L. (2016). Perspectives of nursing faculty in Africa on global health competencies. Nursing Outlook, 64,179–185.http://dx.doi.org/10.1016/j.outlook.2015.11.016.  PMID: 26827192. PMCID: None.
 * 54) *Murphy, J., Mark, H., Anderson, J., Farley, J. E., & Allen J. (2016). A randomized trial of human papillomavirus self-sampling as an intervention to promote cervical cancer screening in women with HIV.  Journal of Lower Genital Tract Disease, 20(2): 139–144. doi: 10.1097/LGT.0000000000000195. PMID: 27015260. PMCID: PMC4808515.
 * 55) Treston, C., Farley, J. E., Harris, O., Hoyt, M. J., Kwong, J., & Van Ays, J. (2015). PrEP works and is a valuable addition to the HIV prevention toolkit. Journal of the Association of Nurses in AIDS Care (JANAC), 26(3): 224-226. doi: 10.1016/j.jana.2015.02.002. PMID: 25869548. PMCID: None.
 * 56) *Farley, J. E., Hayat, M. J., Sacamano, P. L., Ross, T., & Carroll, K. (2015). Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV positive cohort. American Journal of Infection Control (AJIC), 43(4): 329-335. doi: 10.1016/j.ajic.2014.12.024. PMID: 25687358. PMCID: PMC4386874.
 * 57) *Farley, J. E., Kelly, A. M., Reiser, K., Brown, M., Kub, J., Davis, J. G., & Van Der Walt, M. (2014). Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South Africa. PLoS ONE, 18;9(11):e111702. doi: 10.1371/journal.pone.0111702. PMID: 25405988. PMCID: PMC4236054.
 * 58) *Farley, J. E., Hayat, M., Murphy, J., Sheridan-Malone, E., & Mark, H. (2014). Knowledge, attitudes, and practices of OB/GYN nurses and auxiliary staff in the care of pregnant women living in HIV.  Journal of the Association of Nurses in AIDS Care (JANAC), 2(2): 158-167. doi: 10.1016/j.jana.2013.04.004. PMID: 23876818. PMCID: None.
 * 59) *Tudor, C., Van der Walt, M. Margot, B., Dorman, B., Pan, W., Yenokyan, G., & Farley, J. E. (2014).  Tuberculosis among healthcare workers in KwaZulu-Natal, South Africa: a retrospective cohort analysis.  BMC: Public Health, 14: 891. doi: 10.1186/1471-2458-14-891. PMID: 25174848. PMCID: PMC4161912.
 * 60) Willard, S. & Farley, J. E. (2014). ANAC – a vital past…a dynamic future. Journal of the Association of Nurses in AIDS Care, 25(6): 71-72. http://dx.doi.org/10.1016/j.jana.2014.08.003. PMID: None. PMCID: None.
 * 61) Farley, J. E., Landers, T., F., Godfrey, C., Lipke, V., & Sugarman, J. (2014). Optimizing the protection of research participants and personnel in HIV-related research where TB is prevalent: practical solutions for improving infection control. Journal of Acquired Immune Deficiency Syndromes (JAIDS). 1, 65(Suppl 1): S19-23. doi: 10.1097/QAI.0000000000000035. PMID: 24321979. PMCID: PMC3918137.
 * 62) Moscou-Jackson, G., Commodore-Mensah, Y., Farley, J. E., & DiGiacomo, M. (2014). Smoking- cessation interventions in persons living with HIV infection: A systematic review.  Journal of the Association of Nurses in AIDS Care (JANAC), 25(1): 32-45.  doi:10.1016/j.jana.2013.04.005. PMID: 23876816. PMCID: PMC4105340.
 * 63) *Tudor, C., Mphahlele, M., Van der Walt, M., & Farley, J. E. (2013). Health care workers’ fears associated with working in multidrug-and or extensively-resistant tuberculosis wards in South Africa.  International Journal of Tuberculosis and Lung Disease, 17(10 Suppl 1): 22-9. doi: 10.5588/ijtld.13.0109. PMID: 24020597. PMCID: None.
 * 64) Anderson, J. C., Campbell, J., & Farley, J. E. (2013). Interventions to address HIV and intimate partner violence in sub-Saharan Africa: A review of the literature.  Journal of the Association of Nurses in AIDS Care (JANAC), 24(4): 383-390. doi: 10.1016/j.jana.2013.03.003. PMID: 23790280. PMCID: PMC3694280.
 * 65) *Tudor, C., Van der Walt, M., Hill, M., Farley, J. E. (2013). Occupational health policies and practices related to tuberculosis in health care workers in KwaZulu-Natal, South Africa. Public Health Action, 3(2).  http://dx.doi.org/10.588/pha.12.0098. PMID: 26393017. PMCID: PMC4463108.
 * 66) *Van der Walt, M., Lancaster, J., Odendaal, R., Davis, J., Shean, K., & Farley, J. E. (2013). Serious treatment-related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients. PLoS ONE, 8(4) e5587. doi: 10.1371/journal.pone.0058817. PMID: 23573193. PMCID: PMC3615995.
 * 67) *Farley, J. E., Ross, T., Krall, J., Hayat, M., Caston-Gaa, A., Perl, T., & Carroll, K.C. (2013).  Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus nasal and axillary colonization among psychiatric patients on admission to an academic medical center.  American Journal of Infection Control. 41(3): 199-203. doi: 10.1016/j.ajic.2012.03.028. PMID: 22999771. PMCID: None.
 * 68) Willard, S. & Farley, J. E. (2012). Nurses, stemming the leaks to “turn the tide.” Guest Editorial. Journal of the Association of Nurses in AIDS Care (JANAC), 23(6): 473-474. doi: 10.1016/j.jana.2012.08.003. PMID: 23062778. PMCID: None.
 * 69) *Zimmerman, C. E., Stamper, P. D., Bryant, L., Farley, J. E., Golova, J., Holmberg, R., Howard, T., Linger, Y., Meyers, L., Perov, A., Ruby, G. B., Carroll, K. C., & Chandler, P. D. (2012). Development of a simple, low-density array to detect methicillin resistant staphylococcus aureus and mecA dropouts in nasal swabs.  Journal of Microbiological Methods, 91(3): 366-376.  doi: 10.1016/j.mimet.2012.09.010.  PMID: 23041495. PMCID: None.
 * 70) *Mphalele, M., Tudor, C., Van der Walt, M., & Farley, J. E., (2012).  An infection control audit of 10 primary healthcare facilities in western cape, South Africa.  International Journal of Infection Control, 8(3):1-5. Open access: http://www.ijic.info/article/view/10303. doi: 10.3396/ijic.v8i3.10303. PMID: None. PMCID: None.
 * 71) *Wilson, L., Harper, D. C., Tami-Maury, I., Zarate, R., Salas, S, Farley, J. E., Warren, N., Mendes, I., & Ventura, C. (2012).  Global health competencies for nurses in the Americas.  Journal of Professional Nursing, 28(4):213-222. doi: 10.1016/j.profnurs.2011.11.021. PMID: 22818191. PMCID: None.
 * 72) *Farley, J. E., Tudor, C., Mphahlele, M., Franz, K., Perrin, N., Dorman, S., & Van der Walt, M. (2012). A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa. International Journal of Tuberculosis and Lung Disease, 16(1): 82-89. doi: 10.5588/ijtld.10.0791. PMID: 22236851. PMCID: None.
 * 73) *Farley, J. E., Doughman, D., Jeeva, R., Jeffries, P., & Stanley, J. (2012). Department of health and human services releases new immersive simulation experience to improve infection control knowledge and practices among healthcare workers and students.  American Journal of Infection Control, 40(3):258-259. doi: 10.1016/j.ajic.2011.03.024. PMID: 21784556. PMCID: None.
 * 74) *Mark, H, Lucea, M., Nanda, J., Farley, J. E., & Gilbert, L. (2011). Genital herpes testing among persons living with HIV.  Journal of the Association of Nurses in AIDS Care (JANAC), 22(5):354-361. doi: 10.1016/j.jana.2011.01.002. PMID: 21459624. PMCID: None.
 * 75) *Farley, J. E., Ram, M., Pan, W., Waldman, S. E., Cassell, C., Chaisson, R., Weyer, K., & Van der Walt, M. (2011). Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PLoS ONE, 6(7): e20436. E-pub: 2011. doi: 10.1371/journal.pone.0020436. PMID: 21799728. PMCID: PMC3142109.
 * 76) *Stamper, P. D., Louie, L., Wong, H., Simor, A. E., Farley, J. E., & Carroll, K. C. (2011). Genotypic and phenotypic characterization of methicillin-susceptible staphylococcus aureus isolates misidentified as methicillin-resistant staphylococcus aureus by the BD GeneOhmTM MRSA Assay. Journal of Clinical Microbiology, 49(4): 1240-1244. doi: 10.1128/JCM.02220-10. PMID: 21307210. PMCID: PMC3122879.
 * 77) Farley, J. E., Tudor, C., & Dennison, C. (2010).  Progress in prevention: Improving cardiovascular risk management among human immunodeficiency virus-positive individuals.  Journal of Cardiovascular Disease. 25(4): 259-260. doi: 10.1097/JCN.0b013e3181e3aa98. PMID: 20539159. PMCID: PMC3130550.
 * 78) Farley, J. E., & others. (2010). Notes from the decennial: Multi-Author Commentary.  American Journal of Infection Control, 38(5): 337-340. doi: 10.1016/j.ajic.2010.04.197. PMID: 20569847. PMCID: None.
 * 79) *Gilbert, L., Nanda, J., Farley, J. E., & Mark, H. (2010). Providers’ knowledge, practices, and barriers related to genital herpes testing for patients with HIV. Journal of the Association of Nurses in AIDS Care (JANAC), 21(4): 327-334. doi: 10.1016/j.jana.2009.12.009. PMID: 20347347. PMCID: None.
 * 80) *Farley, J. E., Ross, T., Stamper, P. D., Baucom, S., Larson, E., & Carroll, K. C. (2008). Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus among newly arrested men in Baltimore, Maryland. American Journal of Infection Control, 36(9): 644-650. doi: 10.1016/j.ajic.2008.05.005. PMID: 18834755. PMCID: PMC2603277.
 * 81) *Farley, J. E., Stamper, P. D., Ross, T., Cai, M., Speser, S. & Carroll, K. C. (2008). Comparison of BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture use by use of BBLTM CHROMagarTM MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population. Journal of Clinical Microbiology, 46(2): 743-746. doi: 10.1128/JCM.02071-07. PMID: 18057129. PMCID: PMC2238090.
 * 82) Farley, J. E. (2008). Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. The Journal of the American Academy of Nurse Practitioners, 20(2): 85-92. doi: 10.1111/j.1745-7599.2007.00290. PMID: 18271763. PMCID: PMC2688639.
 * 83) Farley, J. E., Dial, D. J., & Kearney, M. (2006). Management of hematologic and neuropsychiatric side effects in persons undergoing treatment for chronic HCV infection. The Journal for Nurse Practitioners, 2, 1: 38-45. https://doi.org/10.1016/j.nurpra.2005.11.012. PMID: None. PMCID: None.
 * 84) *Farley, J. E., Srinivasan, A., Richards, A., Song, X., McEachen, J., & Perl, T. M. (2005). Handheld computer surveillance: Shoe-leather epidemiology in the “palm” of your hand. American Journal of Infection Control, 33(8): 444-449. doi: 10.1016/j.ajic.2005.07.001. PMID: 16216657. PMCID: None.
 * 85) *Berenholtz, S. M., Pronovost, P. J., Lipsett, P., Hobson, D., Earsing, K., Farley, J. E., Milanovich, S., Garrett-Mayer, E., Winters, B. D., Rubin, H., Dorman, T., & Perl, T. M. (2004). Eliminating catheter-related bloodstream infections in intensive care unit. Critical Care Medicine, 32(10): 2014-2020. doi: 10.1097/01.CCM.0000142399.70913.2F.  PMID: 15483409. PMCID: None.
 * 86) *Davis, L. L., Jewell, M. E., Ambrose, S., Farley, J. E., English, B., Bartolucci, A, & Petty, A. (2004). A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: A preliminary study. Journal of Clinical Psychopharmacology, 24(3): 291-297. doi: 10.1097/01.jcp.0000125685.82219.1a. PMID: 15118483. PMCID: None.
 * 87) Catlett, C., & Farley, J. E. (2002). Infection control challenges for the new century: Lessons learned from past epidemics are valuable in healthcare system bioterrorism disaster planning. Seminars in Infection Control, 2,1: 2-9. PMID: None. PMCID: None.

In Review

 * 1) Zhao, A., Dangerfield II, D. T., Nunn, A., Patel, R., Farley, J. E., Ugoji, C., Dean, L. (2021). Pharmacy-based Interventions to Increase Use of HIV Pre-Exposure Prophylaxis in the United States: A Scoping Review. AIDS and Behavior.
 * 2) Schumacher, C. M., Farley, J. E. (2020). Reaching those most at risk for HIV acquisition: Evaluating Racial/Ethnic disparities in the PrEP Care Continuum in Baltimore City, Maryland. Journal of Acquired Immune Deficiency Syndromes (JAIDS).
 * 3) *Farley, J. E., Beuchamp, G., Bergman, A., Hughes, J. P., Batey, D. S., Mayer, K., del Rio, C., Raifman, J., Lowensen, K., Gamble, T., Remien, R., Beyrer, C. (2020). The impact of stigma and sexual identity on PrEP awareness and use among at-risk men who have sex with men in 4 US cities (HPTN 078). AIDS and Behavior.
 * 4) Nguyen, Y., McNabb, K.C., Warren, N., & Farley, J. E. (2020). Pregnancy outcomes during tuberculosis disease and steps taken in the prevention front: A systematic review. International Journal of Nursing Studies.
 * 5) Tsui, S., Kennedy, C., Moulton, L. H., Chang, L. W., Farley, J. E., Torpey, K., Van Praag, E. V.,  Koole, O., Stuart, L. Ford, N., Wabwire-Mangen, F., & Denison, J. A. (2020). HIV care and treatment models and their association with medication possession ratio among treatment-experienced adults in three African countries. AIDS Patient Care and STDs.
 * 6) Bergman, A., McNabb, K., & Farley, J. E. (2020).  A systematic review and psychometric appraisal of instruments measuring tuberculosis stigma in sub-Saharan Africa. International Journal of Tuberculosis and Lung Disease (IJTLD).
 * 7) *Gamble, T., Wang, Z., Gaydos, C., Batey, D.S., Mayer, K.H., del Rio, C., Farley, J. E., Stirrat, M., Adeyeye, A., Stanton, J., McKinstry, L., Cummings, V., Musgrove, K., Dormitzer, J., Lowensen, K., Wilson, E., Hughes, J. P., Remien, R.H. & Beyrer, C. (2019). Finding men who have sex with men (MSM) who may be potential amplified HIV transmitters: results from HPTN 078. Journal of Acquired Immune Deficiency Syndromes (JAIDS).
 * 8) *Malone, J., Baral, S., Wang, Z., del Rio, C. Mayer, K.H., Batey, D.S., Farley, J. E., Gamble, T., Stanton, J., Hughes, J.P., Wilson, E., Irvin, R., Guevara-Perez, O., Bocek, A., Bruce, J., Gaston, R.,  Remien, R. & the HPTN078 Study Team. (2019). Use of deep-chain respondent-driven sampling to identify and engage viremic men who have sex with men living with HIV in four US cities: Results from HPTN 078 (the “work”). Journal of Acquired Immune Deficiency Syndromes (JAIDS).
 * 9) Yan, J., Zhang, A., Reynolds, N., Farley J. E., & Huang, E. (2019). The internet affects the whole processes: The influence of internet practice on sexual identity development of young gay males. Computers in Human Behavior.
 * 10) *Beyrer, C., Malone, J., Baral, S., Wang, Z., del Rio, C. Mayer, K.H., Batey, D.S., Farley, J. E., Gamble, T., Stanton, J., Hughes, J.P., Wilson, E., Irvin, R., Guevara-Perez, O., Bocek, A., Bruce, J., Gaston, R.,  Remien, R. (2020). Using Adaptive Recruitment Strategies to Engage Men Who Have Sex With Men Living with HIV with Unsuppressed Viral Loads in Four US Cities: Results from HPTN 078. Journal of the International AIDS Society (JAIS).